MANKIND PHARMA
|
The Current P/S Ratio of MANKIND PHARMA is 6.66.
| Share Price | ₹2,375.0 | Aug 24,2026 |
| Market Cap | ₹98,087.5 Cr | |
| Sales-TTM | ₹14,737.9 Cr | TTM-Consolidated Results |
| Price/Sales | 6.66x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of MANKIND PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹98,087.5 Cr] as on Aug 24,2026
(/) Sales [ ₹14,737.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 6.66x ]
Thus, for MANKIND PHARMA , the investors are currently willing to pay '6.66 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of MANKIND PHARMA !
The chart below summarizes the trend in P/S Ratio of MANKIND PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of MANKIND PHARMA
PS Ratio Performance Analysis for MANKIND PHARMA
- MANKIND PHARMA 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 4.59x.
- MANKIND PHARMA 's operated at median p/e ratio of 5.8x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MANKIND PHARMA 's p/e ratio peaked in Mar2024 at 8.97x.
- MANKIND PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does MANKIND PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| MANKIND PHARMA | 14,737.9 | 6.66 | 98,087.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.65 | 458,249.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 20.09 | 225,648.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.76 | 184,891.0 |
| CIPLA LTD | 28,324.4 | 4.09 | 115,927.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.00 | 99,702.0 |
| LUPIN LTD | 29,966.6 | 3.34 | 100,134.0 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.84 | 109,825.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.65 | 92,612.8 |
| LAURUS LABS LTD | 7,269.6 | 13.35 | 97,053.6 |
| BIOCON LTD | 17,321.1 | 3.86 | 66,817.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MANKIND PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.65x |
| Max industry PS | 20.09x |
| Median industry PS | 4.09x |
| Average industry PS | 7.30x |
You may also like the below Video Courses